Print

CardioVia
General
Jobs • 0
Shortlists/Awards • 1
Pricing strategy • 0
Partners/Competitors • 0
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors
Details
Legal residence:Israel
Organization type:Consulting organization
Funding agencies: Other, Horizon 2020 (2014 - 2020)
Sectors: Health, Laboratory & Measurement
Status:
Active
About
We at CardioVia are developing minimal invasive access to the outer surface of the heart via the pericardium which is a double-walled sac that surrounds the heart.
The outer surface of the heart has been recognized as a promising entry route for the treatment of the most prevalent cardiovascular diseases such as cardiac tamponade, mapping & ablation for various arrhythmias such as Atrial fibrillation and Ventricular tachycardia, left atrial appendage closure, epicardial lead placement and in the future, epicardial pacemaker implantation, drug, stem cells and gene therapy.
These devices and opportunities will unfold greatly once safely and reliably epicardial access will be achieved. It is estimated that, annually, 2.5M patients in the US and the EU will benefit from epicardial access due to a variety of pathological conditions.
By using cutting edge technologies with the simplest ideas, CardioVia will be able to provide physicians with the right access to perform advanced cardiac treatments on the outer surface of the heart like never seen before. By using CardioVia's device, physicians will be able to perform procedures on one of the most delicate and complicated instruments that the human body has.
Top partners

Top competitors


Similar Companies
By Sectors and Organization Types
Country:
Italy
Awards:
216
Jobs:
0
Country:
Spain
Awards:
3
Jobs:
0
Country:
Denmark
Awards:
344
Jobs:
0
Country:
Switzerland
Awards:
1
Jobs:
0